Literature DB >> 23710757

Neutrophil gelatinase-associated lipocalin and end-stage renal disease: it is not all about the kidneys!

Simon Rau1, Antje Habicht, Teresa Kauke, Andreas Hillmer, Matthias Wessely, Manfred Stangl, Markus Guba, Michael Fischereder, Ulf Schönermarck.   

Abstract

INTRODUCTION: Neutrophil gelatinase-associated lipocalin (NGAL) is a powerful biomarker for the early detection of acute kidney injury. However, recent data suggest that NGAL also plays an important role in chronic kidney disease (CKD), reflecting the level of acute kidney damage within the CKD condition. To study whether elevated NGAL levels in CKD are a consequence of damaged tubular cells or rather due to extrarenal production, we investigated NGAL levels in anephric patients on dialysis.
METHODS: Plasma NGAL levels were investigated in 14 dialysis patients who underwent bilateral nephrectomy (anephric group), 18 anuric dialysis patients with remaining kidneys (dialysis group) and 12 healthy patients (healthy group).
RESULTS: Plasma NGAL levels were significantly lower in the healthy group compared with the anephric group (143 vs. 981 ng/mL; P < 0·001) or the dialysis group (143 vs. 838 ng/mL; P < 0·001), respectively. However, NGAL levels did not differ between the anephric group and the dialysis group (981 vs. 838 ng/mL; P = 0·19). DISCUSSION: Assuming that NGAL is highly expressed in chronically damaged kidneys due to tubular stress, there should be significantly less NGAL in anephric patients compared with anuric dialysis patients with remaining kidneys. In contrast to this hypothesis, we found no difference in NGAL expression between these two groups, proving the entire extrarenal NGAL production in anephric patients and suggesting that the tubular NGAL expression seems to be negligible in anuric dialysis patients.
© 2013 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  End-stage renal disease; haemodialysis; nephrectomy; neutrophil gelatinase-associated lipocalin

Mesh:

Substances:

Year:  2013        PMID: 23710757     DOI: 10.1111/eci.12110

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  4 in total

Review 1.  Proteomic urinary biomarker approach in renal disease: from discovery to implementation.

Authors:  Joost P Schanstra; Harald Mischak
Journal:  Pediatr Nephrol       Date:  2014-03-15       Impact factor: 3.714

2.  Association of plasma neutrophil gelatinase-associated lipocalin with parameters of CKD-MBD in maintenance hemodialysis patients.

Authors:  Xiao-Yan Jia; Kai Wei; Juan Chen; Lin-He Xi; Xiang-Lei Kong; Yong Wei; Li Wang; Zun-Song Wang; Yi-Peng Liu; Li-Ming Liang; Dong-Mei Xu
Journal:  J Bone Miner Metab       Date:  2021-08-15       Impact factor: 2.626

3.  Association of plasma neutrophil gelatinase-associated lipocalin and thoracic aorta calcification in maintenance hemodialysis patients with and without diabetes.

Authors:  Kai Wei; Gesheng Song; Linhe Xi; Juan Chen; Chuancai Sun; Ping Chen; Yong Wei; Li Wang; Xianglei Kong; Yang Li; Dongmei Xu; Xiaoyan Jia
Journal:  BMC Nephrol       Date:  2022-04-22       Impact factor: 2.585

4.  Type of Renal Replacement Therapy (Hemodialysis versus Peritoneal Dialysis) Does Not Affect Cytokine Gene Expression or Clinical Parameters of Renal Transplant Candidates.

Authors:  Dorota Kamińska; Katarzyna Kościelska-Kasprzak; Paweł Chudoba; Oktawia Mazanowska; Mirosław Banasik; Marcelina Żabinska; Maria Boratyńska; Agnieszka Lepiesza; Krzysztof Korta; Agnieszka Gomółkiewicz; Piotr Dzięgiel; Marian Klinger
Journal:  Biomed Res Int       Date:  2015-07-08       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.